Why I Keep Buying AbbVie Stock Despite Market Noise
An investor reveals he bought more AbbVie (ABBV) shares last week and plans to do so again during June's macro-driven dips, viewing the company as a cash machine unaffected by short-term economic fluctuations.
Key Numbers
An investor announced last week that he purchased additional shares of AbbVie (NYSE:ABBV) and intends to repeat the move whenever June's macroeconomic noise creates a discount. While short-term traders focus on sticky 4.2% inflation and a softening labor market, the investor keeps adding shares of what he calls a "cash machine" that is indifferent to such fluctuations.
Details
The investor believes AbbVie's strong business model generates stable cash flows, making it attractive for dividend seekers. He noted that relatively high inflation (4.2%) and a weak jobs market create opportunities to buy the stock at discounted prices.
Context
These comments come amid U.S. inflation above target and slowing employment, which have unsettled markets. However, the investor considers AbbVie insulated from these factors due to its product diversification and brand strength.
What It Means for Investors
This perspective suggests that some investors see current volatility as a chance for long-term investment in reliable dividend stocks, rather than engaging in short-term trading.
Frequently Asked Questions
Found this useful? Share it